Prolintane is a central nervous system (CNS) stimulant[2] and norepinephrine–dopamine reuptake inhibitor (NDRI) developed in the 1950s.

[3] Being an amphetamine derivative, it is closely related in chemical structure to other drugs such as pyrovalerone, MDPV, and propylhexedrine, and has a similar mechanism of action.

[5] Under the brand name Katovit, prolintane was commercialized by the Spanish pharmaceutical company FHER until 2001.

It was most often used by students and workers as a stimulant to provide energy and increase alertness and concentration.

[medical citation needed] This drug article relating to the nervous system is a stub.